Patient-related factors impact the implementation of inpatient antibiotic allergy delabeling
Antibiotic allergy delabeling in the acute care context is not straightforward. Competing clinical concerns and patient acceptance are some barriers to an inpatient service. Nor is it apparent that inpatient versus outpatient testing is cost saving although select patient groups may benefit. Testing younger people and those with predicted high antibiotic usage will derive maximal individual and health system benefits.
Authors
- Ian W. Li (ORCID: https://orcid.org/0000-0002-1438-8830)
- Catherine Willis (ORCID: https://orcid.org/0000-0001-8426-5441)
- Renee Berry (ORCID: https://orcid.org/0000-0002-2363-2540)
- Rishabh Kulkarni (ORCID: https://orcid.org/0009-0009-1941-7379)
- S. Herrmann (ORCID: https://orcid.org/0000-0002-4633-1062)
- Britta Sylvia von Ungern-Sternberg (ORCID: https://orcid.org/0000-0002-8043-8541)
- Kevin Murray (ORCID: https://orcid.org/0000-0002-8856-6046)
- Hana Karuppasamy
- Michelle Trevenen (ORCID: https://orcid.org/0000-0002-0614-8319)
- Michaela Lucas (ORCID: https://orcid.org/0000-0001-8881-9990)
- Niklesh Warrier
Institutions
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Curtin University (AU)
- Princess Margaret Hospital for Children (AU)
- Fiona Stanley Hospital (AU)
- Sir Charles Gairdner Hospital (AU)
- Perth Children's Hospital
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.jacig.2024.100326
- Citations
- 1
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.38
Funders
- Department of Health, Government of Western Australia
- Stan Perron Charitable Foundation
- Tasmanian Department of Health
- National Health and Medical Research Council